


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
PGRE
Paramount Group
SYBX
Synlogic
SUZ
Suzano S.A.
ETON
Eton Pharmaceuticals
IDAI
T Stamp
Most Trending
+9.34%
+1.63%
-8.67%
+20.62%
-7.12%
PGRE
Paramount Group
$6.57
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Risk Analysis

Investors losing their confidence
Chart
$6.53 (+0.61%)
$6.84 (-3.95%)
$6.33 (+3.79%)
$4.75 (+38.32%)
PGRE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

PGRE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Eps growth
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
PGRE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PGRE Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayVRE
15.04
+0.20%
NTST
18.20
-0.87%
LTC
36.11
+0.65%
IVT
27.34
-0.58%
ARE
54.66
-1.71%
What is PGRE current stock price?
What are PGRE stock strengths?
What risks are associated with PGRE stock?
When is PGRE next earnings report?
What is PGRE market cap and volume?
What is PGRE's current Stock IQ?
Should I buy PGRE stock right now?
Is PGRE a Strong Buy right now?
What does a 'Strong Buy' rating mean for PGRE?
What does a 'Strong Sell' rating mean for PGRE?
What factors influence PGRE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
PGRE
Paramount Group
SYBX
Synlogic
SUZ
Suzano S.A.
ETON
Eton Pharmaceuticals
IDAI
T Stamp
Most Trending
+9.34%
+1.63%
-8.67%
+20.62%
-7.12%
PGRE
Paramount Group
Current Price
$6.57
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Risk Analysis

Investors losing their confidence
Linked to PGRE
VRE
15.04
+0.20%
NTST
18.20
-0.87%
LTC
36.11
+0.65%
IVT
27.34
-0.58%
ARE
54.66
-1.71%

Chart
$6.53 (+0.61%)
$6.84 (-3.95%)
$6.33 (+3.79%)
$4.75 (+38.32%)
PGRE Analysts Opinion
PGRE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Eps growth
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
PGRE Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PGRE Street Sentiment is bullish and have positive views on the near-term outlook
PGRE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
PGRE Latest Analysis
A Look at Insight Moleculars Upcoming Earnings Report. Insight Molecular (NASDAQ:) is gearing up to announce its quarterly earnings on Monday 2025-11-10. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Insight Molecular will report an Anticipation surrounds Insight Molecular'.s announcement with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.New investors should understan
Fri Nov 7, 2025
A Look at Microvast Holdingss Upcoming Earnings Report. Microvast Holdings (NASDAQ:MVST) is gearing up to announce its quarterly earnings on Monday 2025-11-10. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Microvast Holdings will report an The market awaits Microvast Holdings'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to u
Fri Nov 7, 2025
Earnings Outlook For Ranger Energy Services. Ranger Energy Services (NYSE:) is preparing to release its quarterly earnings on Monday 2025-11-10. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Ranger Energy Services to report an The market awaits Ranger Energy Services'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand
Fri Nov 7, 2025
Insights into PowerFleets Upcoming Earnings. PowerFleet (NASDAQ:AIOT) is gearing up to announce its quarterly earnings on Monday 2025-11-10. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that PowerFleet will report an PowerFleet s will hope to hear the company announce they'.ve not only beaten that estimate but also to provide positive guidance or forecasted growth for the next quarter.New investors should note that it is sometimes not
Fri Nov 7, 2025
Read Paramounts argument for why its WBD buyout offer is superior to splitting the company. Warner Bros. Discovery plans to announce either a sale or that its moving forward with splitting the company — or both — by Christmas sources told CNBC.
Wed Nov 5, 2025
Preview: QXOs Earnings. QXO (NYSE:) is gearing up to announce its quarterly earnings on Thursday 2025-11-06. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that QXO will report an QXO s will hope to hear the company announce they'.ve not only beaten that estimate but also to provide positive guidance or forecasted growth for the next quarter.New investors should note that it is sometimes not an earnings beat or miss that most affects the
Wed Nov 5, 2025
Examining the Future: Insulets Earnings Outlook. Insulet (NASDAQ:PODD) will release its quarterly earnings report on Thursday 2025-11-06. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate Insulet to report an The market awaits Insulet'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand that guidance can be a significant driver of stock pri
Wed Nov 5, 2025
An Overview of Tapestrys Earnings. Tapestry (NYSE:) is preparing to release its quarterly earnings on Thursday 2025-11-06. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Tapestry to report an Tapestry s will hope to hear the company announce they'.ve not only beaten that estimate but also to provide positive guidance or forecasted growth for the next quarter.New investors should note that it is sometimes not an earnings beat or miss
Wed Nov 5, 2025
Paramount and PBR Announce Landmark Five-Year Media Rights Deal. Paramount to Become Streaming Home of PBR Unleash The BeastUnleash The Beast starting in the 2026 season beginning Under the agreement Paramount will stream live coverage of the full PBR Unleash The Beast (UTB) season – the highest level of individual riding competition spanning five months in 19 cities across 17 states. The partnership builds on the long-standing relationship between PBR and CBS Sports which began in 2013 and run
Wed Nov 5, 2025
JP Morgan Maintains Paramount Skydance (PSKY) Underweight Recommendation. Fintel reports that on November 4 2025 JP Morgan maintained coverage of Paramount Skydance (NasdaqGS:PSKY) with a Underweight recommendation. Analyst Price Forecast Suggests 11.94% Downside
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PGRE Stock trends
PGRE Stock performance
PGRE Stock analysis
PGRE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.